Enter a job title or keyword

Chemist Conjugation Expert


Job Location:

Arlesheim - Switzerland

Monthly Salary: Not provided by the employer
Posted: 23 October 2026 (5 days ago)
Application Deadline: 20 January 2027
Vacancies: 1 Vacancy

Job Summary

About this position

The Chemist / Conjugation Expert acts as SME for the development optimization and scale-up of bioconjugation processes for our antibody-based therapeutic portfolio. As a key technical contributor you will define conjugation strategies establish critical process parameters and appropriate process controls and support product and process characterization to ensure robust reproducible and scalable manufacturing of the payloads and ADCs. With your technical expertise you will supervise programs from R&D through clinical development including technology transfer and GMP manufacturing readiness while working closely with internal CMC Quality and Regulatory functions. The role includes oversight of technical activities performed by CDMOs and other external partners troubleshooting of process-related issues and contribution to CMC documentation and regulatory submissions.

Your tasks:

  • Lead the development optimization characterization and scale-up of robust and reproducible antibody conjugation processes from early development through clinical manufacturing.

  • Serve as the subject matter expert for conjugation chemistry and process development providing scientific guidance reviewing technical data and leading troubleshooting and root-cause investigations for process-related issues.

  • Collaborate with the CMC Lead and the Quality manager to establish appropriate analytical control strategies and support product characterization comparability assessments stability studies and investigations.

  • Define critical process parameters process controls and scale-up strategies and support technology transfer process validation readiness and GMP manufacturing activities at external manufacturing sites.

  • Manage technical interactions with CDMOs and external development partners including preparation and review of development plans protocols reports batch documentation technical proposals timelines and deliverables.

  • Contribute to CMC development strategies and author or review relevant technical documentation for regulatory submissions responses to health authority questions and internal governance reviews.

Role requirements
  • PhD in Chemistry Chemical Biology Biochemistry Pharmaceutical Sciences or a related scientific discipline with a strong foundation in protein chemistry and bioconjugation.

  • At least 5 years of relevant industry experience in bioconjugation process development or CMC development of AxCs products including site-specific conjugation technologies linker-payload chemistry or other complex bioconjugate modalities

  • Demonstrated expertise in bioconjugation chemistry and antibody-related technologies including reaction optimization purification and characterization of conjugated products.

  • Hands-on experience in process development scale-up technology transfer and technical support of manufacturing activities preferably involving external partners or CDMOs.

  • Good understanding of GMP requirements and experience supporting clinical-stage development including preparation or review of technical and CMC documentation.

  • Strong scientific communication problem-solving and project leadership skills with the ability to work effectively across functions and manage technical activities with external partners.

  • Fluent in written and spoken English; additional languages are a plus.

  • A flexible agile and hands-on mindset with the ability to adapt priorities and operate effectively in a fast-paced biotech environment.

  • Work location: on site in Allschwil with up to 2 days home office.

Work permit

Candidate needs to hold a Swiss work permit or be an EU citizen eligible to work in Switzerland.

Your path forward

If you meet these requirements and are dedicated to advancing bioconjugation processes for our antibody-based therapeutic portfolio we look forward to receiving your application. Join us in our mission to develop innovative therapies for patients in need.


About Company

Company Logo

Alentis is the leading biotech company developing anti-Claudin-1 therapies. Claudin-1 is an extraordinary target that plays a key role in many solid tumors and fibrosis. We are committed to unlocking the broad potential of Claudin-1 and bringing much-needed new medicines to patients.

View Profile View Profile